Magnesium in PDB 8x21: Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex
Protein crystallography data
The structure of Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex, PDB code: 8x21
was solved by
Y.Yasutake,
S.I.Hattori,
H.Mitsuya,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.67 /
2.33
|
Space group
|
H 3
|
Cell size a, b, c (Å), α, β, γ (°)
|
284.447,
284.447,
95.728,
90,
90,
120
|
R / Rfree (%)
|
17.5 /
21.8
|
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex
(pdb code 8x21). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the
Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex, PDB code: 8x21:
Jump to Magnesium binding site number:
1;
2;
Magnesium binding site 1 out
of 2 in 8x21
Go back to
Magnesium Binding Sites List in 8x21
Magnesium binding site 1 out
of 2 in the Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg602
b:61.7
occ:1.00
|
O2B
|
A:ET9601
|
1.9
|
72.7
|
1.0
|
O
|
A:VAL111
|
1.9
|
67.5
|
1.0
|
O1G
|
A:ET9601
|
2.2
|
77.0
|
1.0
|
OD2
|
A:ASP185
|
2.3
|
62.7
|
1.0
|
OD1
|
A:ASP110
|
2.6
|
80.6
|
1.0
|
O1A
|
A:ET9601
|
2.6
|
83.0
|
1.0
|
PB
|
A:ET9601
|
3.0
|
82.5
|
1.0
|
C
|
A:VAL111
|
3.2
|
54.6
|
1.0
|
CG
|
A:ASP185
|
3.2
|
54.0
|
1.0
|
PG
|
A:ET9601
|
3.4
|
81.8
|
1.0
|
O3B
|
A:ET9601
|
3.5
|
87.1
|
1.0
|
O3A
|
A:ET9601
|
3.5
|
94.2
|
1.0
|
PA
|
A:ET9601
|
3.6
|
86.6
|
1.0
|
CG
|
A:ASP110
|
3.7
|
77.2
|
1.0
|
OD1
|
A:ASP185
|
3.8
|
55.0
|
1.0
|
CA
|
A:GLY112
|
4.1
|
50.9
|
1.0
|
N
|
A:GLY112
|
4.1
|
51.0
|
1.0
|
N
|
A:ASP113
|
4.1
|
44.0
|
1.0
|
N
|
A:VAL111
|
4.2
|
49.4
|
1.0
|
NZ
|
A:LYS220
|
4.2
|
84.1
|
1.0
|
CB
|
A:ASP185
|
4.2
|
47.4
|
1.0
|
CA
|
A:VAL111
|
4.2
|
52.1
|
1.0
|
O1B
|
A:ET9601
|
4.3
|
71.6
|
1.0
|
O3G
|
A:ET9601
|
4.3
|
85.2
|
1.0
|
CB
|
A:ALA114
|
4.3
|
39.4
|
1.0
|
C5'
|
A:ET9601
|
4.3
|
68.2
|
1.0
|
C
|
A:GLY112
|
4.3
|
51.5
|
1.0
|
N
|
A:ALA114
|
4.3
|
46.5
|
1.0
|
O5'
|
A:ET9601
|
4.4
|
79.5
|
1.0
|
O2G
|
A:ET9601
|
4.4
|
82.7
|
1.0
|
OD2
|
A:ASP110
|
4.4
|
79.7
|
1.0
|
CB
|
A:VAL111
|
4.7
|
48.9
|
1.0
|
C
|
A:ASP110
|
4.7
|
51.0
|
1.0
|
CB
|
A:ASP110
|
4.7
|
63.1
|
1.0
|
O2A
|
A:ET9601
|
4.8
|
92.4
|
1.0
|
CA
|
A:ALA114
|
4.9
|
44.0
|
1.0
|
|
Magnesium binding site 2 out
of 2 in 8x21
Go back to
Magnesium Binding Sites List in 8x21
Magnesium binding site 2 out
of 2 in the Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Hiv-1 Reverse Transcriptase Mutant Q151M/Y115F/F116Y/L74V:Dna:Etv-Tp Ternary Complex within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg602
b:65.8
occ:1.00
|
O
|
C:VAL111
|
1.8
|
89.7
|
1.0
|
O2B
|
C:ET9601
|
2.1
|
72.4
|
1.0
|
O3G
|
C:ET9601
|
2.2
|
82.0
|
1.0
|
OD2
|
C:ASP185
|
2.2
|
82.7
|
1.0
|
OD2
|
C:ASP110
|
2.4
|
83.8
|
1.0
|
O1A
|
C:ET9601
|
2.6
|
88.8
|
1.0
|
C
|
C:VAL111
|
3.0
|
73.9
|
1.0
|
PB
|
C:ET9601
|
3.2
|
84.4
|
1.0
|
CG
|
C:ASP185
|
3.3
|
67.9
|
1.0
|
PG
|
C:ET9601
|
3.4
|
90.6
|
1.0
|
CG
|
C:ASP110
|
3.5
|
78.2
|
1.0
|
O3B
|
C:ET9601
|
3.6
|
89.1
|
1.0
|
PA
|
C:ET9601
|
3.7
|
90.8
|
1.0
|
O3A
|
C:ET9601
|
3.7
|
92.3
|
1.0
|
N
|
C:VAL111
|
3.8
|
65.8
|
1.0
|
OD1
|
C:ASP185
|
3.8
|
65.3
|
1.0
|
N
|
C:GLY112
|
3.9
|
73.0
|
1.0
|
CA
|
C:VAL111
|
3.9
|
67.5
|
1.0
|
CA
|
C:GLY112
|
4.0
|
70.8
|
1.0
|
N
|
C:ASP113
|
4.1
|
72.2
|
1.0
|
O2G
|
C:ET9601
|
4.2
|
94.2
|
1.0
|
C
|
C:ASP110
|
4.3
|
67.7
|
1.0
|
OD1
|
C:ASP110
|
4.3
|
76.9
|
1.0
|
C
|
C:GLY112
|
4.3
|
69.7
|
1.0
|
C5'
|
C:ET9601
|
4.4
|
80.0
|
1.0
|
NZ
|
C:LYS220
|
4.4
|
85.2
|
1.0
|
CB
|
C:ASP110
|
4.4
|
71.6
|
1.0
|
O1G
|
C:ET9601
|
4.5
|
93.9
|
1.0
|
O1B
|
C:ET9601
|
4.5
|
81.6
|
1.0
|
CD
|
C:LYS220
|
4.5
|
84.3
|
1.0
|
CB
|
C:ASP185
|
4.5
|
60.1
|
1.0
|
O5'
|
C:ET9601
|
4.6
|
87.0
|
1.0
|
CB
|
C:VAL111
|
4.6
|
63.0
|
1.0
|
N
|
C:ALA114
|
4.6
|
59.7
|
1.0
|
CB
|
C:ALA114
|
4.7
|
57.3
|
1.0
|
O
|
C:ASP110
|
4.8
|
71.7
|
1.0
|
CA
|
C:ASP110
|
4.9
|
64.1
|
1.0
|
O2A
|
C:ET9601
|
4.9
|
96.4
|
1.0
|
CE
|
C:LYS220
|
4.9
|
85.1
|
1.0
|
O
|
C:ASP185
|
5.0
|
57.4
|
1.0
|
|
Reference:
Y.Yasutake,
S.I.Hattori,
H.Kumamoto,
N.Tamura,
K.Maeda,
H.Mitsuya.
Deviated Binding of Anti-Hbv Nucleoside Analog E-Cfcp-Tp to the Reverse Transcriptase Active Site Attenuates the Effect of Drug-Resistant Mutations. Sci Rep V. 14 15742 2024.
ISSN: ESSN 2045-2322
PubMed: 38977798
DOI: 10.1038/S41598-024-66505-Z
Page generated: Sat Oct 5 00:58:34 2024
|